Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
137.8 USD | +1.37% | +2.02% | +3.49% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.49% | 13.68B | |
-2.00% | 103B | |
+2.12% | 95.28B | |
+2.42% | 22.15B | |
-15.98% | 21.02B | |
-8.75% | 18.15B | |
-41.01% | 16.73B | |
-13.67% | 16.05B | |
+33.55% | 12.17B | |
-23.57% | 8.24B |
- Stock Market
- Equities
- NBIX Stock
- News Neurocrine Biosciences, Inc.
- Neurocrine Biosciences Says US FDA Accepts Supplemental NDA for Valbenazine for Chorea Linked to Huntington Disease